Aprotinin clinical trials
How each study uses Aprotinin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Aprotinin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 1993 · TRASYLOL · BLA 020304 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2020 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 4
Bayer (4) · Imperial College London (1) · Nycomed (1) · Nemours Children's Clinic (1) · Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion (1) · Dartmouth-Hitchcock Medical Center (1) · Aviron LLC (1)
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses Aprotinin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome TreatmentRecruitingPhase 3Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la IntegracionNCT07317050Written as Aprotinin (inhaled)How we know
- An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19Status unknownNot applicableAviron LLCNCT04527133Written as AprotininHow we know
- Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion SurgeryTerminatedPhase 3BayerNCT00327379Written as Trasylol (Aprotinin, BAYA0128)How we know
- Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary BypassCompletedNot applicableImperial College LondonNCT00131040Written as AprotininHow we know
- Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip ReplacementCompletedPhase 3BayerNCT00668031Written as Trasylol (Aprotinin, BAYA0128)How we know
- Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total CystectomyTerminatedPhase 3BayerNCT00306150Written as Trasylol (Aprotinin, BAYA0128)How we know
- Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal CancerTerminatedPhase 3BayerNCT00306137Written as Trasylol (Aprotinin, BAYA0128)How we know
- Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)CompletedPhase 4NycomedNCT00290836Written as Human fibrinogen/thrombin and bovine aprotinin (TachoComb H)How we know
- Can Aprotinin Reduce Pancreatitis After Scoliosis SurgeryCompletedPhase 1Nemours Children's ClinicNCT00357851Written as AprotininHow we know
- Phase I Study of Aprotinin in Advanced Breast CancerTerminatedPhase 1Dartmouth-Hitchcock Medical CenterNCT00354900Written as AprotininHow we know
Codes
What other systems call Aprotinin · ClinicalTrials.gg INT007703
- MeSH (NLM) D007611AprotininConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 04XPW8C0FLAPROTININConfirmed FDA, Wikidata
- RxNorm 1056Confirmed FDA, Wikidata
- Wikidata Q418625aprotininConfirmed FDA, Wikidata
- NCI Thesaurus C47402AprotininOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007611 | Aprotinin | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 04XPW8C0FL | APROTININ | Confirmed FDA, Wikidata |
| RxNorm | 1056 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418625 | aprotinin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C47402 | Aprotinin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.